NCT04229459 2026-01-14
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
Rabin Medical Center
Phase 2 Active not recruiting
Rabin Medical Center
Taiho Oncology, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC